Alnylam Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES
Last updated:
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) targeting an APOC3 gene, and methods of using the dsRNA to inhibit expression of APOC3.
Status:
Application
Type:
Utility
Filling date:
24 Jun 2021
Issue date:
17 Feb 2022